CoChat

Evidence That the 11 β-Hydroxysteroid Dehydrogenase (11 β-HSD1) Is Regulated by Pentose Pathway Flux

Open access
McCormick, Kenneth L., Wang, Xudong, Mick, Gail J. · 2006 · Journal of Biological Chemistry

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyzes the interconversion of biologically inactive 11 keto derivatives (cortisone, 11-dehydrocorticosterone) to active glucocorticoids (cortisol, corticosterone) in fat, liver, and other tissues. It is located in the intraluminal compartment of the endoplasmic reticulum. Inasmuch as an oxo-reductase requires NADPH, we reasoned that 11 beta-HSD1 would be metabolically interconnected with the cytosolic pentose pathway because this pathway is the primary producer of reduced cellular pyridine nucleotides. To test this theory, 11 beta-HSD1 activity and pentose pathway were simultaneously measured in isolated intact rodent adipocytes. Established inhibitors of NAPDH production via the pentose pathway (dehydroandrostenedione or norepinephrine) inhibited 11 beta-HSD1 oxo-reductase while decreasing cellular NADPH content. Conversely these compounds slightly augmented the reverse, or dehydrogenase, reaction of 11 beta-HSD1. Importantly, using isolated intact microsomes, the inhibitors did not directly alter the tandem microsomal 11 beta-HSD1 and hexose-6-phosphate dehydrogenase enzyme unit. Metabolites of 11 beta-HSD1 (corticosterone or 11-dehydrocorticosterone) inhibited or increased pentose flux, respectively, demonstrating metabolic interconnectivity. Using isolated intact liver or fat microsomes, glucose-6 phosphate stimulated 11 beta-HSD1 oxo-reductase, and this effect was blocked by selective inhibitors of glucose-6-phosphate transport. In summary, we have demonstrated a metabolic interconnection between pentose pathway and 11 beta-HSD1 oxo-reductase activities that is dependent on cytosolic NADPH production. These observations link cytosolic carbohydrate flux with paracrine glucocorticoid formation. The clinical relevance of these findings may be germane to the regulation of paracrine glucocorticoid formation in disturbed nutritional states such as obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m506026200

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE1 Effect of DHEAandNEonpentosepathwayand11 𝛃 -HSD1oxo-reductase activity. Isolated intact fat cells were incubated with and without modifiers for 45 min and then metabolic assays conducted over an additional 90-min interval as seen under 'ExperimentalProcedures.' A , pentose pathwayactivity was measuredwithandwithout 100 𝛍 MDHEA.Thebasal(noadditions) rate was 2.01 ± 0.3 ng/h/10 5 cells and with DHEA 0.87 ± 2.58. B , 11 𝛃 -HSD1 oxo-reductase activity with and without 100 𝛍 M DHEA. The basal rate was 30.7 ± 2.58 ng/h/10 5 cells and with DHEA 12.26 ± 3.58. C , pentose pathway activity was measured with and without 1 𝛍 M NE. The basal rate was 1.62 ± 0.1 ng/h/10 5 cells and with NE 0.79 ± 0.2. D , 11 𝛃 -HSD1 oxo-reductase activity with and without 1 𝛍 M NE. The basal rate was 33.7 ± 8.0 ng/h/10 5 cells and with NE 20.5 ± 7.9. Results given represent the mean ± S.D. of three independent experiments. Statistical comparisons for the effect of modifier on activities are by paired t -test versus no additions.
FIGURE1 Effect of DHEAandNEonpentosepathwayand11 𝛃 -HSD1oxo-reductase activity. Isolated intact fat cells were incubated with and without modifiers for 45 min and then metabolic assays conducted over an additional 90-min interval as seen under 'ExperimentalProcedures.' A , pentose pathwayactivity was measuredwithandwithout 100 𝛍 MDHEA.Thebasal(noadditions) rate was 2.01 ± 0.3 ng/h/10 5 cells and with DHEA 0.87 ± 2.58. B , 11 𝛃 -HSD1 oxo-reductase activity with and without 100 𝛍 M DHEA. The basal rate was 30.7 ± 2.58 ng/h/10 5 cells and with DHEA 12.26 ± 3.58. C , pentose pathway activity was measured with and without 1 𝛍 M NE. The basal rate was 1.62 ± 0.1 ng/h/10 5 cells and with NE 0.79 ± 0.2. D , 11 𝛃 -HSD1 oxo-reductase activity with and without 1 𝛍 M NE. The basal rate was 33.7 ± 8.0 ng/h/10 5 cells and with NE 20.5 ± 7.9. Results given represent the mean ± S.D. of three independent experiments. Statistical comparisons for the effect of modifier on activities are by paired t -test versus no additions.CC-BY · From the PDF
FIGURE 2 Effect of DHEA and NE on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Intact liver microsomes (50 𝛍 g of protein/ml) were preincubated for 60 min with modifiers (1 or 10 𝛍 M NE and 10 or 100 𝛍 M DHEA), and then 11 𝛃 -HSD1 oxo-reductase activity was measured over 45 min in the incubation medium as shown under 'Experimental Procedures.' Results are given as a percent of control (no additions) and represent the mean ± S.D. for three separate experiments. There were no statistical differences for effect of modifier over control (no addition) by paired t -test. The control rate was 317 ± 52 ng corticosterone/h/mg protein.
FIGURE 2 Effect of DHEA and NE on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Intact liver microsomes (50 𝛍 g of protein/ml) were preincubated for 60 min with modifiers (1 or 10 𝛍 M NE and 10 or 100 𝛍 M DHEA), and then 11 𝛃 -HSD1 oxo-reductase activity was measured over 45 min in the incubation medium as shown under 'Experimental Procedures.' Results are given as a percent of control (no additions) and represent the mean ± S.D. for three separate experiments. There were no statistical differences for effect of modifier over control (no addition) by paired t -test. The control rate was 317 ± 52 ng corticosterone/h/mg protein.CC-BY · From the PDF
FIGURE 3 Effect of DHEA and NE on the dehydrogenase reaction of 11 𝛃 -HSD1. Adipocytes were prepared fresh and preincubated for 45 min with 100 𝛍 MDHEAor1 𝛍 M NE. 11 𝛃 -HSD1 dehydrogenase activity was measured as shown under 'Experimental Procedures' as the disappearance of radiolabeled corticosterone over time. Results are expressed relative to control (no modifier). Statistical comparisons for the effect of either modifier on 11 𝛃 -HSD1 dehydrogenase activity are by paired t -test versus no additions (mean ± S.D., n = 3). The basal dehydrogenase rate was 0.9 ± 0.06 ng/h/10 5 cells.
FIGURE 3 Effect of DHEA and NE on the dehydrogenase reaction of 11 𝛃 -HSD1. Adipocytes were prepared fresh and preincubated for 45 min with 100 𝛍 MDHEAor1 𝛍 M NE. 11 𝛃 -HSD1 dehydrogenase activity was measured as shown under 'Experimental Procedures' as the disappearance of radiolabeled corticosterone over time. Results are expressed relative to control (no modifier). Statistical comparisons for the effect of either modifier on 11 𝛃 -HSD1 dehydrogenase activity are by paired t -test versus no additions (mean ± S.D., n = 3). The basal dehydrogenase rate was 0.9 ± 0.06 ng/h/10 5 cells.CC-BY · From the PDF
FIGURE 4 Regulation of pentose pathway by substrates of 11 𝛃 -HSD1 enzyme ( 11DHC and corticosterone ). Fat cells were preincubated with 10 𝛍 M 11-DHC or 10 𝛍 M corticosterone for 30 min, and then pentose pathway flux was measured over 90 min as shown under 'Experimental Procedures'. Results are given for three experiments and expressed as mean ± S.D. relative to control (no additions). Statistical differences by paired t -test are shown. The control (no additions) rate of pentose pathway activity was 7.14 ± 9.5 nmol/h/10 5 adipocytes.
FIGURE 4 Regulation of pentose pathway by substrates of 11 𝛃 -HSD1 enzyme ( 11DHC and corticosterone ). Fat cells were preincubated with 10 𝛍 M 11-DHC or 10 𝛍 M corticosterone for 30 min, and then pentose pathway flux was measured over 90 min as shown under 'Experimental Procedures'. Results are given for three experiments and expressed as mean ± S.D. relative to control (no additions). Statistical differences by paired t -test are shown. The control (no additions) rate of pentose pathway activity was 7.14 ± 9.5 nmol/h/10 5 adipocytes.CC-BY · From the PDF
FIGURE 5 Glucose-6-phosphate ( G6P ) effect on 11 𝛃 -HSD1 oxo-reductase in microsomes. Rat liver microsomes (50 mg of protein/ml) were preincubated for 30 min with 0-10 mM G6P, and then 11 𝛃 -HSD1 oxo-reductase was measured for 45 min as shown under 'Experimental Procedures.' Results from three experiments (mean ± S.D.) are expressed relative to basal (no added G6P).
FIGURE 5 Glucose-6-phosphate ( G6P ) effect on 11 𝛃 -HSD1 oxo-reductase in microsomes. Rat liver microsomes (50 mg of protein/ml) were preincubated for 30 min with 0-10 mM G6P, and then 11 𝛃 -HSD1 oxo-reductase was measured for 45 min as shown under 'Experimental Procedures.' Results from three experiments (mean ± S.D.) are expressed relative to basal (no added G6P).CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIGURE 7 Effect of the G6P translocase inhibitor, chlorogenic acid, on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Liver microsomes (50 𝛍 g/ml) were preincubatedfor60minwithandwithout0.5mMchlorogenicacidandeither0.5 𝛍 MG6Por1mM galactose-1-phosphate. 11 𝛃 -HSD1 oxo-reductase activity was then measured over 45 min. One representative experiment is shown.
FIGURE 7 Effect of the G6P translocase inhibitor, chlorogenic acid, on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Liver microsomes (50 𝛍 g/ml) were preincubatedfor60minwithandwithout0.5mMchlorogenicacidandeither0.5 𝛍 MG6Por1mM galactose-1-phosphate. 11 𝛃 -HSD1 oxo-reductase activity was then measured over 45 min. One representative experiment is shown.CC-BY · From the PDF
FIGURE 8 Effect of DHEA and NE on adipocyte NADPH content. Fat cells were incubated with 100 𝛍 M DHEA or 1 𝛍 M NE, and then total cellular NADPH content was measured in washed fat cells by a radioisotopic assay as shown under 'Experimental Procedures.' Results are from four independent experiments and are presented as mean ± S.D. relative to control (no additions) with statistical differences by paired t -test (shown). The NADPH content of the control adipocytes was 8.6 ± 2.2 pmol/10 6 cells.
FIGURE 8 Effect of DHEA and NE on adipocyte NADPH content. Fat cells were incubated with 100 𝛍 M DHEA or 1 𝛍 M NE, and then total cellular NADPH content was measured in washed fat cells by a radioisotopic assay as shown under 'Experimental Procedures.' Results are from four independent experiments and are presented as mean ± S.D. relative to control (no additions) with statistical differences by paired t -test (shown). The NADPH content of the control adipocytes was 8.6 ± 2.2 pmol/10 6 cells.CC-BY · From the PDF
FIGURE 9 Effect of pyridine nucleotides on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Rat liver microsomes (50 𝛍 g/ml) were preincubated for 60 min at 37 °C with the pyridine nucleotides noted (each at final concentration of 1 mM) and then 11 𝛃 -HSD1 oxo-reductase activity measured over 45 min as shown under 'Experimental Procedures'. Results are expressed relative to basal (no modifier, no G6P) for three separate experiments (mean ± S.D.). The control rate was 239 ± 70 ng of corticosterone/ h/mg protein. Statistical differences are by paired t -test.
FIGURE 9 Effect of pyridine nucleotides on liver microsomal 11 𝛃 -HSD1 oxo-reductase activity. Rat liver microsomes (50 𝛍 g/ml) were preincubated for 60 min at 37 °C with the pyridine nucleotides noted (each at final concentration of 1 mM) and then 11 𝛃 -HSD1 oxo-reductase activity measured over 45 min as shown under 'Experimental Procedures'. Results are expressed relative to basal (no modifier, no G6P) for three separate experiments (mean ± S.D.). The control rate was 239 ± 70 ng of corticosterone/ h/mg protein. Statistical differences are by paired t -test.CC-BY · From the PDF
FIGURE 10 Schematic illustration of proposed metabolic interconnection between cytosolic pentose pathway and 11 𝛃 -HSD1 in the endoplasmic reticulum ( ER ). Glucose enters the cell via a plasma membrane transporter ( T ) and is phosphorylated to glucose-6-phosphate ( G-6-phosphate ). This hexose phosphate is metabolized via glycolysis or the cytosolic oxidative pentose pathway (wherein NADP is converted to NADPH), or it may also be transported via its specific transporter ( T ) directly into the ER. NADPH produced in the cytosol accesses the ER via an uncertain mechanism, graphically depicted here as a pore for the sake of simplicity. This cytosolic-derived NADPH is then utilized by the intraluminal 11 𝛃 -HSD1 oxo-reductase to convert the biologically inert 11 dehydrocorticosterone (or cortisone in humans) to biologically active corticosterone (or cortisol in humans). Also depicted is hexose-6- phosphate dehydrogenase ( H6PD ), residing proximate to 11 𝛃 -HSD1, which can locally produce NADPH within the ER space from transported G-6-phosphate.
FIGURE 10 Schematic illustration of proposed metabolic interconnection between cytosolic pentose pathway and 11 𝛃 -HSD1 in the endoplasmic reticulum ( ER ). Glucose enters the cell via a plasma membrane transporter ( T ) and is phosphorylated to glucose-6-phosphate ( G-6-phosphate ). This hexose phosphate is metabolized via glycolysis or the cytosolic oxidative pentose pathway (wherein NADP is converted to NADPH), or it may also be transported via its specific transporter ( T ) directly into the ER. NADPH produced in the cytosol accesses the ER via an uncertain mechanism, graphically depicted here as a pore for the sake of simplicity. This cytosolic-derived NADPH is then utilized by the intraluminal 11 𝛃 -HSD1 oxo-reductase to convert the biologically inert 11 dehydrocorticosterone (or cortisone in humans) to biologically active corticosterone (or cortisol in humans). Also depicted is hexose-6- phosphate dehydrogenase ( H6PD ), residing proximate to 11 𝛃 -HSD1, which can locally produce NADPH within the ER space from transported G-6-phosphate.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. Ricketts, 1998, J. Clin. Endocrinol. Metab., 83, 1325
  2. Bujalska, 2002, J. Clin. Endocrinol. Metab., 87, 1205
  3. Ottosson, 1994, J. Clin. Endocrinol. Metab., 79, 820
  4. Stewart, 1999, J. Clin. Endocrinol. Metab., 84, 1022
  5. Richardson, 1978, Am. J. Physiol., 234, E182
  6. Whorwood, 2001, J. Clin. Endocrinol. Metab., 86, 2296

Cited by

See all 72

Metadata

Authors
McCormick, K. L., Wang, X., & Mick, G. J.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
McCormick, Kenneth L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-01
Volume
281
Issue
1
Pages
341-347
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2065060742
Cited by
72
References
64
Citations by year
2024: 2 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 8 · 2012: 4
FWCI
5.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
11β-hydroxysteroid dehydrogenase type 1, pentose phosphate pathway, NADPH, glucocorticoid metabolism, adipocytes, endoplasmic reticulum, glucose-6-phosphate, hexose-6-phosphate dehydrogenase, corticosterone, 11-dehydrocorticosterone, obesity
MeSH terms
Adjuvants, Immunologic, Animals, Cells, Cultured, Dehydroepiandrosterone, Enzyme Activation, Microsomes, Liver, Monosaccharide Transport Proteins, NADP, Norepinephrine, Pentose Phosphate Pathway, Sympathomimetics, Adipocytes, Antiporters, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.